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Summanr The chemoprotective effect of vanadium, a dietary micronutnrent. against chemically induced
hepatocarcinogenesis in rats was investigated. Initiation was performed by a single intraperitoneal injection of
diethylnitrosamine (DENA; 200 mg kg-') followed by promotion with phenobarbital (0.05%) in the diet.
Supplementary vanadium (0.5 p.p.m.) in the drinking water was provided ad libitum throughout the experi-
ment. before the initiation or during the promotion period. At the end of the study (20 weeks). vanadium
supplementation throughout the experiment reduced the incidence (P<0.01). total number and multiplicity
(P<0.001) and altered the size distribution of visible persistent nodules (PNs) as compared with DENA
control animals. Mean nodular volume (P<0.05) and nodular volume as a percentage of liver volume
(P<0.01) were also attenuated following long-term vanadium treatment. It also caused a large decrease in the
number (P<0.001) and surface area (P<0.01) of 7-glutamyltranspeptidase (GGT)-positive hepatocyte foci and
in the labelling index (P<0.001) of focal cells, coupled with increased (P<0.01) remodelling. The activity of
GGT, measured quantitatively, was found to be significantly less in the PNs (P<0.001) and non-nodular
surrounding parenchyma (P<0.01) of vanadium-supplemented rats. The anticarcinogenic effect of vanadium
was also reflected in the histopathological analysis of liver sections that showed a well-maintained hepatocel-
lular architecture as compared with DENA control. Similar results were observed when vanadium was given
only before the initiation. However, supplementation of vanadium during the promotion penrod did not result
in significant alterations of these parameters. Our results, thus, strongly suggest that vanadium may have a
unique anti-tumour potential which is primarily exerted on the initiation phase and only secondarily on the
promotion stage.
Keywords: vanadium: diethylnitrosamine: hepatocarcinogenesis: persistent nodules: hepatocyte foci:
chemoprevention
Research on the biological influence of vanadium, a ubi-
quitous transition metal, has grown enormously during the
past several years owing to its toxicological impact as an
environmental pollutant as well as its role as a dietary trace
element (Nechay et al., 1986; Sabbioni et al., 1991, 1993:
French and Jones, 1993; Bishayee and Chatterjee, 1994).
Scanning of pertinent literature reveals that many naturally
occurring products and trace elements present in various
foods may prevent, halt or reverse the neoplastic process
(Wattenberg, 1985; Greenwald et al., 1987). Vanadium, an
endogenous constituent of all or most mammalian tissues, is
believed to have a regulatory role in biological systems
(Crans et al., 1989; Gullapalli et al., 1989). Studies carried
out in the last decade suggest that this transition metal could
be considered a representative of a new class of non-platinum
group metal anti-tumour agents (Kopf-Maier, 1987).
Although Kingsnorth et al. (1986) observed that vanadate
supplementation in diet or drinking water had little or no
effect on 1,2-dimethylhydrazine-induced colon cancer in mice.
Djordjevic and Wampler (1985) reported a significant anti-
tumour activity of vanadium complexes against L1210
murine leukaemia. Vanadium at > 10-6M inhibited in vitro
tumour colony formation, as was evident from a human
tumour cloning assay (Hanauske et al., 1987). Dietary
vanadium was found to block the induction of murine mam-
mary carcinogenesis by 1-methyl-l-nitrosourea (Thompson et
al., 1984). Previously, we have documented a significant pro-
tective response of vanadium (Sardar et al.. 1993) and its
possible biochemical mechanism (Chakraborty and Chatter-
jee, 1994) against the growth of a transplantable murine
lymphoma.
In a recent communication, we have reported for the first
time that vanadium at 0.5 p.p.m. in drinking water was very
effective in arresting the development of diethylnitrosamine
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(DENA)-induced hepatocarcinogenesis in rats without any
toxic manifestations (Bishayee and Chatterjee, 1995). The
observed chemoprotective action of vanadium was found to
be mediated through inhibition of altered liver cell foci and
hepatic nodule growth during the early stages of neoplastic
transformation (Bishayee and Chatterjee. 1995). However, in
this study vanadium supplementation was done during the
entire course of our experiment and it was not possible to
ascertain at which time point this trace element was most
effective. In order to explore this area, we initiated a new
series of experiments in which the anticarcinogenic potential
of vanadium was critically examined before the initiation as
well as during the early promotion phase of experimentally
induced hepatocarcinogenesis. Our present study is an
attempt to gain more quantitative information regarding the
morphometric analysis of y-glutamyltranspeptidase (GGT)-
positive hepatocyte foci and nodules together with remodell-
ing and altered enzyme activities of GGT in the presence or
absence of vanadium during DENA-induced hepatocarcino-
genesis in rats. The rationale behind the selection of these
parameters lies in the fact that hepatocyte foci demonstrating
altered enzyme phenotypes including GGT expression are
generally accepted to be the putative preneoplastic lesions for
hepatocellular carcinoma and their quantitative analysis is a
useful tool for evaluation of modulation of hepatocarcino-
genesis in rats (Pitot and Sirica. 1980; Farber, 1984a; Wil-
liams, 1989). We selected DENA as the initiator carcinogen
because of its low hepatotoxic and high hepatocarcinogenic
properties (Scherer and Emmelot, 1976) and for its presence
in different food products (Coker et al.. 1991) and tobacco
smoke (Serfontein and Hurter. 1966).
Materials and methods
Animals and diet
Male Sprague-Dawley rats (from the Indian Institute of
Chemical Biology, Calcutta. India) weighing 110- 120 g atVanadium and lIr cwd
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the beginning of the experiments were used in this study. The
animals were housed in plastic cages (four rats per cage) in
an air-conditioned room maintained at a temperature of
23 ± 1°C and relative humidity of 55 ± 5% with a 6 a.m.-6
p.m. photoperiod and were supplied with a semipurified basal
diet and double-distilled demineralised drinking water ad
libitum. The detailed composition of the semipurified diet is
given in Table I. It takes into account the contents of amino
acids, vitamins and minerals present in Torula yeast (Candida
utilis) and provides normal growth and maintenance of rats
(Aquino et al.. 1985). The animals were acclimatised to the
facility 1 week before the commencement of the experiments.
Experimental design
To investigate the chemopreventive efficacy of vanadium and
to identify the stage(s) at which it could be effective against
chemical hepatocarcinogenesis. the rats were divided ran-
domly into eight experimental groups as depicted in Figure I
according to the experimental regimen previously designed by
us (Sarkar et al.. 1994). Animals in groups A. C. E and G
were submitted to a slightly modified two-stage hepatocar-
cinogenesis model of Yoshiji et al. (1991). Initiation was
performed by a single intraperitoneal (i.p.) injection of
DENA (Sigma. St Louis. MO. USA) at a dose of 200 mg
kg-' body weight in 0.9% sodium chloride solution. Follow-
mg a 2 week recovery penrod. phenobarbital (PB) (Sigma).
the promoter. was incorporated into the basal diets of the
above four groups (i.e. groups A. C. E and G) at the level of
0.05% for 14 successive weeks. Group A animals were the
carcinogen (DENA) control. while group B animals served as
untreated normal controls. Vanadium, as ammonium
monovanadate (E. Merck. India). was added to the double-
distilled, demineralised drinking water at a concentration of
Table I Composition of the semipunfied diet
Ingredients Per cent bi weight
Torula yeast 40.0
Sucrose 37.9
Dextrin 10.0
Cellulose 4.0
Corn oil 5.0
DL-Methionine 0.5
Mineral mixVa 2.1
Vitamin mix' 0.5
'Provided (g kg-' diet) calcium carbonate 19.6; sodium chloride 1.2:
manganese sulphate 0.06: and potassium iodate 0.001. bProvided (kg-'
diet) retinyl acetate 1250 IUL cholecaliferol 120 IUL menadione 100 g:
vitamin B,. 5 jg: and tocopheryl acetate 200 mg.
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Figure 1 Schematic representation of the experimental regimen.
DENA (200 mg kg-'. ip.); =I. basal diet and normal drin-
king water: _. basal diet with PB (0.05%) and normal drink-
ing water: M. basal diet and vanadium supplementation (0.5
p.p.m.) in drinking water: M. basal diet with PB (0.05%) and
vanadium supplementation (0.5 p.p.m.) in drinking water: time
of sacrifice.
0.5 p.p.m. and given ad libitum to the rats of all groups
except groups A and B.
As illustrated in Figure 1. group C animals received the
vanadium supplementation during the entire length of the
experiment (for 20 consecutive weeks). starting the treatment
4 weeks before initiation with DENA (throughout the experi-
ment study). In group E, vanadium was given for only four
consecutive weeks before initiation (initiation study). Group
G animals received supplementary vanadium I week after
initiation and this was continued until the end of the experi-
ment. i.e. a total of 15 successive weeks (promotion study).
The animals from groups D. F and H served, respectively, as
vanadium controls for groups C. E and G and received
vanadium supplementation for 20. 4 and 15 consecutive
weeks respectively. Solutions of vanadium were renewed
every 2-3 days. Daily food and water intakes were noted
and the weights of the animals from each group were
recorded every second day. All animals were sacrificed by
decapitation 20 weeks after the start of the experiment. For
the last 4 days of the study. PB was withdrawn from the
basal diet in order to eliminate background activities of GGT
in liver according to Perera et al. (1987). Animals were fasted
overnight before sacrifice.
Morphology, histologyl and histochemistrv
After the rats were sacrificed, their livers were promptly
excised. blotted, weighed and then examined macroscopically
on the surface as well as in 3 mm cross-sections for gross
visible persistent nodules (PNs). which represented focal pro-
liferating, GGT-positive hepatic lesions with a low tendency
to spontaneous regression (Farber. 1984b). The PNs were
easily identified from the reddish-brown non-nodular sur-
rounding parenchyma (NNSP) by their greyish-white colour
and sharp demarcation. The PNs, which approximated
spheres. were measured in two perpendicular directions to the
nearest millimetre to obtain an average diameter of each
nodule. The PNs were categorised into three groups accord-
ing to their diameter (namely > 3, < 3 - 1 and < I mm) as
described by Moreno et al. (1991). From these diameters,
individual nodule volumes were calculated.
Representative sections from right, left and caudate lobes
of each liver were taken. They were fixed in an ice-cold
mixture of dehydrated ethanol and glacial acetic acid (19:1)
for 4 h followed by an overnight incubation in 99.5% ethanol
at 4'C and then embedded in soft paraffin (m.p. 47'C) for
histological and histochemical examination of liver sections.
Two contiguous paraffin sections were made, one for routine
haematoxylin and eosin (H&E) staining and one for GGT
histochemistry according to the method of Rutenberg et al.
(1969). Quantitative evaluation of GGT-positive hepatic foci
(lesions smaller than a liver lobule mainly visible micros-
copically) were performed as described by Campbell et al.
(1982). Each rat had between 8 and 10 cm2 of liver cross-
section examined for GGT transections. and sample identity
was unknown during the morphometric analysis. Remodell-
ing lesions were identified as areas lacking uniformity for
GGT histochemistry and exhibiting irregular boundaries with
surrounding liver and relatively low labelling index
(Tatematsu et al.. 1983). To determine the labelling index of
GGT-positive hepatocytes, the rats were given tritiated
thymidine (90 Ci mmol') i.p. at the dose of 0.5 guCi g-' body
weight every 6 h for 48 h before sacrifice. The liver slices
were fixed, processed for histochemistry and H&E staining
and labelling indices were evaluated according to the proce-
dure of Garcea et al. (1989). The labelling index values are
expressed as the percentage of hepatocytes that incorporated
tntiated thymidine and were identified as labelled
hepatocytes. A hepatocyte was considered labelled if at least
ten silver grains were observed directly overlying the nucleus
(Marsman and Popp. 1994).
Biochemical estimation ofGGT
The cytosolic fraction from PNs and NNSP was prepared as
described previously (Sarkar et al., 1994). The enzymatic
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activity of GGT in cytosol was measured according to an
adaptation of the method of Tate and Meister (1974). The
cytosolic fraction was preincubated with 1% deoxycholic acid
at 25°C for 15 min. The standard reaction mixture (1 ml)
contained 0.05 M Tris-HCI buffer (pH 8.0). 75 mM sodium
chloride. 20 mM glycylglycine (Sigma) (pH 8.0). 2.5 mM L-y-
glutamyl-p-nitroanilide (Sigma) as the substrate and a
suitable amount of the enzyme preparation. The reaction
mixture was incubated at 37'C for 5 min and the reaction
was initiated by the addition of the substrate. The rate of
release of p-nitroaniline was followed at 410 nm in a Hitachi
U-2000 spectrophotometer. Protein concentration in cytosolic
fraction was assayed by the method of Lowry et al. (1951).
Statistical analysis
The comparison between incidence of PNs in different groups
were performed by Fisher's exact probability test. Differences
between the means were evaluated by means of Student's
t-test.
Results
Food and water intakes
During the entire period of our study, no differences in food
and water consumption were observed among the various
groups of animals. Food and water intakes were
8.7-10.8 g 100-' g day-' and 16.6-18.9 ml 100-' g day-'
respectively for all rat groups.
Mortality
Three rats from different expenrmental groups died before the
end of the study (i.e. 20 weeks): two from group A (16.6%)
and one from group G (8.3%). None of the rats from any
other groups died during the specified period.
Body and liver weights
Table II shows the final body weight, liver weight and
relative liver weight of different groups of rats that were
killed after 20 weeks of the study. The final body weight of
the carcinogen (DENA) control group (group A) was slightly
lower (not statistically sigificant) than that of the untreated
normal controls (group B). Treatment with vanadium (0.5
p.p.m.) increased the final body weights of animals in groups
C. E and G as compared with group A and maintained the
normal body weights of animals in groups D, F and H as
compared with group B, suggesting that the vanadium supp-
lementation in this study had practically no adverse effect on
the growth responses of the rats. There were no significant
differences among the groups in their liver weights. On the
other hand, the relative liver weight in the rats of group A
was found to be significantly higher (P<0.02) than that of
group B. Although vanadium supplementation reduced the
relative liver weights in groups C. E and G as compared with
group A, the result was statistically significant (P<0.05)
only in group C. This could be because of a tendency for
vanadium-supplemented animals to maintain and recover
their body weights faster, showing a better resistance against
the aggression manifested by the particular hepatocar-
cinogenesis model employed and to the smaller number of
PNs present in their livers, as indicated in Table III.
Effect ofvanadium on nodule growth
There were no visible hepatocyte nodules in the liver of
normal control (group B) as well as vanadium control groups
(i.e groups D, F and H). Table III summan'ses the incidence
of nodules, total number of nodules and average number per
nodule-bearing liver of DENA-treated groups in the presence
or absence of vanadium. Significantly decreased (P<0.01)
incidence of PNs was observed in the group that received
vanadium supplementation throughout the experiment
(group C) as compared with the DENA controls (group A).
The group which was provided with vanadium only for four
successive weeks before initiation (group E) or for 15 con-
secutive weeks during the promotional event (group G) also
exhibited reduced nodule incidence when compared with
group A. but the results were statistically insignificant.
Although the total number of PNs was found to be much
less in the three vanadium-treated groups (i.e. groups C, E
and G) than in group A. the result was most pronounced in
group C. Similarly. the average number of nodules per
nodule-bearing liver (nodule multiplicity) was found to be
smaller in groups C. E and G than in group A, but the result
was statistically significant only in groups C (P<0.001) and
E (P<0.02).
Tablen Bodyandliverweightsofdifferent groupsofrats attheendofthestudy(after20weeks)
Relative liver weight
Effective no. Final body Liver weight (g liver 100-'g
Group ofrats weight (gi (gJ bodv}
A 10 279 ± 30.1a 13.10 ± 3.21 4.68 ± 0.41b
B 7 308.5 22.3 10.11 ± 1.95 3.27 ± 0.25
C 12 299.8 ± 25.7 10.81 ± 2.15 3.60 ± 0.31c
D 8 313.3 23.8 10.53 ± 1.72 3.36±0.26
E 12 303.7 28.5 11.93 ± 2.81 3.92 ± 0.35
F 8 299.4 26.1 9.85 ± 1.89 3.28 ± 0.24
G 11 283.7 32.5 12.15 ± 3.12 4.28 ± 0.37
H 7 305.2 29.3 11.02 ± 2.11 3.61 ± 0.33
'Each value represents the mean ± s.e. bP<0.02 as compared with group B. cP<0.05 as
compared with group A.
Table III Effect of sanadium supplementation (0.5 p.p.m.) on the development of persistent
nodules in the livers of rats initiated with DENA and promoted by PB
No. ofrats Nodule Average no. ofnodules
with nodules per incidence Total no. per nodule-bearing
Group total no. ofrats 0%0 ofnodules liver (nodule multiplicity
A 10 10 100 383 38.3 ± 5.8a
C 5 12 41.6 52 10.4 2.7'
E 712 58.3 136 19.4 3.8d
G 8 11 72.7 241 30.1 ±4.7
'Each value represents the mean ± s.e. bP<O0 I as compared with group A by Fisher's exact
probability test. 'P<0.001 as compared With group A and dP<0.02
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Table IV demonstrates the size distribution of PNs, mean
nodular volume and nodular volume as a percentage of liver
volume of different experimental groups of rats. Supplemen-
tary vanadium characteristically reduced the appearance of
PNs of more than 3 mm in size in groups C, E and G as
compared with group A. Mean nodular volume was found to
be inhibited following vanadium supplementation as com-
pared with group A, but a statistically significant (P<0.05)
result was obtained only with group C. There was a
significant decrease (P<0.01) in nodule volume as percen-
tage of liver volume in group C as compared with group A
though an insignificant decrease in this feature was observed
in the other two vanadium-supplemented groups (i.e. groups
E and G).
Effect ofvanadiwn on induction ofGGT-positivefoci
While the livers of rats in normal group (group B) as well as
vanadium control groups (i.e. groups D, F and H) were
found to be normal in terms of histochemical observations,
the GGT-positive foci developed in all DENA-treated
groups. In groups C and E, vanadium supplementation
significantly (P<0.001 and 0.05 respectively) attenuated
GGT-positive foci development (no. cm-) in comparison
with group A (Table V). A significantly decreased (P<0.01)
GGT-positive focal area and percentage of liver parenchyma
occupied by foci were also observed in group C as compared
with group A. In the presence of vanadium, GGT-positive
lesions remodelled to greater extents, as could be seen from
the lack of uniformity of GGT histochemistry and irregular
outlines (non-uniform foci) coupled with low labelling index
(Table V). However, the results were found to be mostly
pronounced and statistically significant in group C as com-
pared with group A.
Effect ofvanadium on hepatic histology
Phenotypically altered hepatocyte populations including PNs
were found scattered in the livers of all DENA-treated
groups (i.e. groups A, C, E and G) but no such alterations
were noticeable in untreated normal controls (group B) or in
vanadium controls (i.e. groups D, F and H) (data not
shown). The H&E-stained sections of liver slices revealed
focal changes that were clearly distinguishable from the sur-
rounding normal parenchyma. In group A, a gross alteration
in hepatocellular architecture was found and the hepatocytes
appeared oval in shape. The altered hepatocytes of foci and
nodules were found to be consistently enlarged with more
than one nucleus, which were largely vesiculated. Some nuclei
in the cells were large and hyperchromatic with prominent
and centrally located nucleoli. Extensive vacuolation was
observed in the cytoplasm around the nucleus with masses of
acidophilic material. In contrast, the cellular architecture of
hepatic lobules seemed to be almost like normal liver in
group C, which received vanadium supplementation during
the entire period of the study. Liver sections from this group
presented only a few clear cell foci. The cells were generally
filled with cytoplasmic material and were less vacuolated
than group A. The size of the nuclei was essentially the same
as that of normal cells, and cells with two nuclei were
considerably fewer than in group A. In group E, i.e. the
group which received vanadium only before initiation, a
predominance of clear rather than acidophilic cell foci was
seen. Cells with two nuclei were less common than in group
A and the size of the nuclei appeared similar to that of
normal cells. However, a moderate improvement in vacuola-
tion and compactness of hepatocytes in group E was evident
when compared with group A, but these improvements over
group A were of lesser extent as compared with group C.
Treatments of rats with vanadium during the promotional
phase (group G) only marginally improved the hepatocellular
phenotype from group A, as was revealed by histological
examination (data not shown).
Effect of vanadium on hepatic enzymatic activity ofGGT
The enzymatic activity ofGGT in the cytosol of PNs induced
by DENA alone (group A), as measured quantitatively, was
more than 72-fold greater than that found in the liver of
untreated controls (group B) and about 2.8-fold higher than
in NNSP (Table VI). Vanadium suppklmentation was found
to be effective in reducing the high activity of GGT in both
the PNs and NNSP significantly in groups C and E and
insignificantly in group G as compared with group A. Here
also vanadium-mediated reduction in GGT activity was max-
imally observed in group C animals. On the other hand, no
significant alteration in GGT activity was noticed in
vanadium control rats (i.e. groups D, F and H) as compared
with their normal counterparts (group B).
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Table IV Effect ofvanadium suppkmentation (0.5 p.p.m.) on the size distribution and growth
ofpersistent nodules in the livers of rats initiated with DENA and promoted by PB
Nodules relative to size Mean nodular Nodular
No. of (% oftotal no.) vohle volwne/liver
Group rats .23mm <3->1mm <]mm (CM3) volune" (%)
A 10 40.2 30.8 28.9 1.42 ± 0.27c 68.4 ± 6.3
C 5 26.9 34.6 38.4 0.74 ± 0.09" 40.2 ± 4.8e
E 7 34.5 33.8 31.6 0.93 0.15 53.2 5.2
G 8 37.3 29.8 32.7 1.19 ± 0.21 60.1 ± 5.8
aIndividual nodule volumes were alculated from twoperpendicular diameters on each nodule.
bOne gram ofliver was assumed to occupy 1cm3 for thiscalkulation. cEach value represents the
mean ± s.e. dp<O.05 and 'P<0.0l as compared with group A.
Table V Influence ofvanadium supplementation (0.5 p.p.m.) on the induction ofGGT-positive livercell foci in rats
initiated with DENA followed by promotion with PB
% area of
No. of No. of Focal area liverparenchyma Non-uniform
Group rats foci Cm-2 (mm ) occupied bvfoci (%) foci Labelling index
A 10 26.7± 35a 0.48 0.06 8.25 0.52 11.31 2.11 2.31 ±0.08
C 12 7.3 ± 0.6b 0.29± 0.OlC 6.12 ± 0.32c 32.70 ± 5.50c 1.62 0.06b
E 12 16.7±2.5d 0.34±0.07 7.37±0.46 18.78 3.10 2.13±0.05
G 11 20.1 ± 3.0 0.41 ± 0.05 7.92 ± 0.56 16.51 ± 3.22 2.21 ± 0.07
'Each value represents the mean ± s.e. bP<0.001, cP<0.01 and dp<0.05 as compared with group A.Vanadium and likw c
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Table VI Alterations in theenzy*matic activity ofcytosolic GGT in the
livers of rats of different expenrmental groups
GGT activits
/nmolproduct formed min- mg- protein)
PNs NNSP Control
Group n = (5/n =5 (n=4)
A 56.90 ± 7.21'b 20.38 3.70 ' 0.78 0.10
C 12.15± 2 .90cd 5.12 1.11 0.83 0.12
E 23.25 ± 4.12b 9.31 ± 2.45c" 0.72 ± 0.09
G 37.81 ± 6.41 b 14.17 3.92 E 0.87 0.13
aEach value represents the mean ± s.e. bP<0.001. cP<0.01 and
'P< 0.02 as compared with the corresponding control. i.e. groups
B,D.F and H for groups A.C.E and G respectively. dp<0O. l.
'P<O.OI and fP< 0 05 as compared with group A.
Discussion
The results of our present investigation clearly demonstrate
that in this particular two-stage model of hepatocar-
cinogenesis in rats the supplementation of 0.5 p.p.m.
vanadium during the entire experiment, before initiation and
during promotion greatly reduced the incidence, multiplicity
and size of visible PNs with a concurrent arrest in the
number and spread of GGT-positive hepatic foci in total
liver parenchyma. In the promotional event, however, these
changes did not have any statistical significance. Our data.
thus, reveal the unique protective role of vanadium against
chemically induced liver tumorigenesis in rats and cor-
roborate our previous findings (Bishayee and Chatterjee.
1995). This time the anticarcinogenic potential of vanadium
is primarily observed on the initiation phase and only secon-
darily on the promotion stage. In this regard, it is interesting
to note that continuous long-term exposure to a low dose of
vanadium would elicit a greater protection in terms of the
magnitude of preneoplasia than exposure at either the initia-
tion or promotion phase alone.
In our experiment. the supplementation of 0.5 p.p.m.
vanadium in drinking water, especially during the entire
period of the study. resulted in fewer rats developing visible
PNs and a smaller number of nodules per nodule-bearing rat
liver than those observed in DENA control animals. Another
st'king observation of the study was the vanadium-mediated
inhibition of the appearance of PNs more than 3 mm in size
with a concurrent attenuation of nodular volume as well as
nodular volume as a percentage of liver volume. Although it
is evident that not all the hepatocyte nodules become
cancerous during the lifespan of the animals. numerous
observations support the concept that the nodules are the
precursors of hepatic cancer (Farber. 1980; Williams. 1980).
Moreover, there is a large body of observational experience
in experimental and human disease correlating the number
and size of nodular hyperplasia and hepatocarcinoma
(Farber and Cameron. 1980: Farber. 1990). In view of this.
inhibition of nodule growth and enhancement of their regres-
sion by vanadium as observed in our study may be important
for cancer prevention. especially if one considers that the
PNs are easily recognisable and have a low tendency to
regress spontaneously. Again, the food and fluid intakes and
changes in body weights among different experimental groups
were found to be statistically similar. This feature is of
paramount importance because nutritional deprivation caus-
ing body weight loss may parallel a decrease in tumour
volume (Waitzberg et al.. 1989). Thus. the observed
inhibitory effect of vanadium on nodule appearance and its
growth is unlikely to be mediated through the impairment of
nutritional status in the experimental animals.
It is generally accepted that GGT-positive foci appear to
be the first discernible evidence for the occurrence of tumour
initiation (Farber. 1980: Pitot and Sirica. 1980). Moreover.
the use of GGT-positive foci in initiation-promotion bioas-
say is predicted on the assumption that the incidence of foci
correlates with the eventual tumour yield that would have
occurred had the assav continued until tumour formation
(Farber. 1980: Pereira. 1982). In the present study. our
results clearly showed an inhibitory role of vanadium on the
number of GOT-positive preneoplastic focal lesions per cmn
of the livers of rats initiated with DENA. As GGT-positive
foci represent a transient step to malignancy (Tatematsu et
al.. 1988). the ability of vanadium to reduce the development
of GGT-positive foci suggests that this trace element can
greatly affect the initiation stages of hepatocarcinogenesis by
preventing the initiated cells from growing into preneoplastic
foci through an alteration in the efficiency at which DENA
can initiate foci appearance. The potential role of vanadium
in reducing the number of foci per cmr of liver area was also
reflected through a relatively high remodelling and low labell-
ing index. This strongly indicates that a progressive loss of
growth capacity by putative preneoplastic cells and their
differentiation into normal-appearing hepatocytes proceed to
a greater extent in the presence of vanadium.
According to the well-accepted hypothesis of Pitot et al.
(1989). the number and size of altered liver cell foci indicate
initiating and promoting activities respectively. In our study.
vanadium supplementation not only decreased the number of
GGT-positive preneoplastic foci but also caused a decrement
in the focal area with a concomitant reduction in focal area
as a percentage of liver area, though the results were statis-
tically more significant with respect to focal number. How-
ever. this strongly points out the influence of vanadium in
inhibiting or slowing the growth of altered liver cell foci. The
observed effect of vanadium on focal growth may represent a
selective toxicity to proliferating cells by virtue of the fact
that they are proliferating compared with a relatively non-
proliferating background and thereby eventually suppress the
occurrence of hepatocarcinogenesis. In this regard. it is inter-
esting to note that, although GGT-positive foci appeared in
the livers of all the vanadium-treated rats concomitant with
DENA administration (foci incidence 100%). only a few rats
exhibited PNs in their livers (nodule incidence 41.6-72.7% in
the three vanadium-supplemented groups). Since PNs arise
from enzyme-altered focal growth (Feo et al.. 1988). our
present findings could be explained in the light of the fact
that. although the precursor lesions were still present in the
livers of vanadium-exposed rats. their growth rate slowed to
such an extent that appearance of PNs was delayed beyond
the experimental end point owing to an increased latency
penod. This interpretation is supported by our histological
assessment, in which the livers of vanadium-supplemented
animals (specially in groups C and E) presented a well-
maintained liver architecture with relatively less acidophilic
hepatocyte areas than DENA controls.
The enzymatic activity of GGT has been identified as a
possible positive marker for preneoplastic hepatocytes
(Cameron et al.. 1978: Hanigan and Pitot. 1985). In the
current study its activity was measured quantitatively in
different cell populations during the induction of liver cancer
with DENA in the presence or absence of vanadium.
Although GGT activity is located inside the plasma memb-
rane, we performed our study using cytosol as it is generally
released in a soluble form by homogenisation. Elhkim et al.
(1992) also observed that at least 80% of the total GGT
activity was present in the cytosolic fraction. Further. PB is
known to be a very weak inducer of GOT alone and, in
combination with the initiating carcinogen DENA. the induc-
tion increases greatly (Shirai et al.. 1985). The exponential
increase in the activity of GGT in PNs and NNSP following
DENA injection as observed here resembled a growth pro-
cess which onrginated as a response to toxic cellular injury.
As there is evidence for a close connection between GGT
activation and carcinogenesis (Fiala and Fiala. 1973). a large
increase in this enzyme activity could be correlated with a
high nodule incidence, a high total number and a large
spread of nodules and foci in hepatic tissue. Vanadium-
mediated inhibition of GOT-positive hepatocyte foci and
PNs during rat liver carcinogenesis initiated with DENA and
promoted by PB was well reflected in the relatively low level
of this enzymatic activity, which was best observed in theVanadium and lIr carciogene
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group in which treatment with vanadium continued through-
out the study. This might indicate a change in the plasma
membrane of the cells that could be related to the ultimate
development of neoplasia. since membrane changes are most
easily related theoretically to neoplastic behaviour (Nicolson.
1976).
DENA and other nitrosamines are thought to confer their
carcinogenic action through their metabolic activation,
generating DNA-binding alkylating agents (Swenberg et al..
1991). Thus. it is likely that the observed inhibitory effect of
vanadium on rat liver carcinogenesis may be related to some
modification of the metabolic activation and/or detoxification
of the particular carcinogen employed. We previously
observed that subchronic oral administration of vanadium at
very low doses significantly elevates the activity of hepatic
and intestinal glutathione S-transferase (GST) in rats
(Bishayee and Chatterjee. 1993). GST is a well-known
cytosolic phase II enzyme which adds functional groups to
the carcinogen, thereby lowering its biological activity and
increasing its excretability. Recently, the induction of GST
enzyme activity has been suggested to be a protective
mechanism of a number of naturally occurring dietary
anticarcinogens (Tanaka, 1992; Wattenberg, 1992; Zheng et
al.. 1992: Nijhoff et al., 1993). The induction of GST by
vanadium could lead to enhanced carcinogen elimination as
well as a reduction in carcinogen-DNA adduct formation
and subsequent expression of preneoplastic lesions and
ultimately neoplasia. This may be one of the underlying
biochemical mechanisms of the chemopreventive action of
this dietary micronutnrent. However, full appreciation of this
needs further study.
Regardless of the mechanism, based on the results reported
here, vanadium could be considered a potential cancer
chemopreventive agent whose effect is presumably based on
inhibition of growth of preneoplastic tissue, coupled with its
remodelling to normal-appearing liver tissue. This attribute
could be considered important, as this trace element may
open new perspectives for the clinical therapy of malignancies
in human subjects in whom exposure history. genetics or
other predisposing events raise the probability of occurrence
of cancer to an alarmingly high level.
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